Copyright © 2017 PerkinElmer, Inc. 400374_05 All rights reserved. PerkinElmer® is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners.


ASSAYS FOR IMMUNO-ONCOLOGY


RESEARCH THAT SUIT YOU TO A “T”


Get the keys to unlock the next blockbuster immunotherapy


Immuno-oncology is one of the most exciting new developments in cancer research. A deep understanding of important targets like PD-1 and PD-L1 could be the key to unlocking the next blockbuster immunotherapy, kickstarting the body’s own immune response to fight cancer. Our Alpha Technology immunoassays are the perfect fit for that research, providing a broad range of reproducible, highly sensitive, no-wash solutions for high-throughput screening and biomarker validation, including ready-to-use kits, customizable toolbox reagents, and full custom assay development services. There’s no work more important – and now you have the tools to move it forward.


Learn more at www.perkinelmer.com/IOassays


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72